kanjinti-powd-for-conc-for-soln-for-infusion-150-mg

Kanjinti powd for conc for soln for infusion 150 mg (150 mg)

Manufacturer: Amgen

Distributor: Zuellig

Contents: trastuzumab

MIMS Class: Targeted Cancer Therapy

Form: Vial

Shape: Undefined

Exclusive offer for doctors

Register for a MIMS account and receive free medical publications worth $768 a year.

Already a member? Sign in